BioCentury
ARTICLE | Clinical News

Sativex sublingual cannabis extract spray: Updated Phase III data

November 19, 2007 8:00 AM UTC

Researchers published in Pain previously reported data from a double-blind, placebo-controlled Phase III trial in 125 patients with neuropathic pain who failed previous analgesic therapy showing that ...